Pro Stock Quote PRW - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

Pro-Pharmaceuticals Provides Year-End Update

Pro-Pharmaceuticals, Inc. (the ?Company?) (NYSE Alternext US: PRW), today provided an update regarding the company?s proposed rights offering, pre-New Drug Application (NDA...

Pro-Pharmaceuticals Files Registration Statement for Rights Offering to Its Shareholders

Pro-Pharmaceuticals, Inc. (the ?Company?) (NYSE Alternext US: PRW) today has filed a registration statement with the Securities and Exchange Commission for its previously...

Pro-Pharmaceuticals to Commence Rights Offering to Shareholders

Pro-Pharmaceuticals, Inc. (NYSE Alternext US: PRW) announced that the Board of Directors has approved a rights offering to its shareholders whereby the Company will distribute...

Pro-Pharmaceuticals Receives Delisting Notice from NYSE Alternext US

Pro-Pharmaceuticals, Inc. (NYSE Alternext US: PRW) received?a letter dated?November 7, 2008 from the NYSE Alternext US (the "Exchange"), formerly known as the American Stock...

Pro-Pharmaceuticals Reports Third Quarter Results

Pro-Pharmaceuticals, Inc. (AMEX: PRW), a bio-pharmaceutical company developing proprietary polysaccharide-based therapeutics in the treatment of cancer and fibrosis, today...

Pro-Pharmaceuticals to Present Corporate Update at the Rodman & Renshaw Annual Global Investment Conference

Pro-Pharmaceuticals, Inc. (Amex: PRW) today announced that Theodore Zucconi, Ph.D., President, Pro-Pharmaceuticals, is scheduled to present a corporate update at the Rodman...

Pro-Pharmaceuticals' Pre-NDA Meeting Scheduled with FDA

Pro-Pharmaceuticals, Inc. (Amex: PRW) today announced that a pre-New Drug Application (?NDA?) meeting with the U.S. Food & Drug Administration (?FDA?) is scheduled for...

Pro-Pharmaceuticals' Management Outlines Strategic Initiatives

The senior management of Pro-Pharmaceuticals, Inc. (AMEX: PRW), has outlined strategic initiatives that will reallocate corporate resources in order to extend the Company?s...

FDA Grants IND for Pro-Pharmaceuticals' DAVANAT(R) to Treat Breast Cancer Patient

Pro-Pharmaceuticals, Inc. (Amex: PRW), today announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of...

Pro-Pharmaceuticals Reports Second Quarter Results

Pro-Pharmaceuticals, Inc. (AMEX: PRW), a bio-pharmaceutical company developing proprietary polysaccharide-based therapeutic compounds in the treatment of cancer and fibrosis...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VINEFresh Vine Wine Inc	$ 0.8001 (9.60%)	299.91k
MITQMoving iMage Technologies Inc	$ 0.60 (6.82%)	1.84k
SOXLDirexion Daily Semiconductor Bull 3X Shares	$ 37.311 (4.40%)	4.03M
KULRKULR Technology Group Inc	$ 0.2888 (3.51%)	37.64k
KORUDirexion Daily South Korea Bull 3X Shares	$ 7.05 (3.22%)	40.01k
MMAAlta Global Group Limited	$ 1.92 (-7.75%)	3.91k
NBYNovaBay Pharmaceuticals Inc New	$ 0.64 (-7.25%)	4.68k
ATCHAtlasClear Holdings Inc	$ 0.28 (-6.04%)	940.46k
SOXSDirexion Daily Semiconductor Bear 3X Shares New	$ 20.1399 (-4.23%)	2.21M
SGNSigning Day Sports Inc	$ 0.2894 (-3.57%)	59k
FXIiShares China Large Cap	$ 29.61 (0.17%)	9.07M
XLFFinancial Select Sector	$ 44.78 (-0.02%)	6.82M
EEMiShares MSCI Emerging Markets	$ 45.09 (0.09%)	5.8M
SPYSPDR S&P 500	$ 570.29 (0.04%)	5.7M
VOOVanguard S&P 500	$ 525.81 (0.04%)	4.61M